What drove the pre-market gain in 1ST.AX stock?

The pre-market gain to A$0.011 was driven by heavy buying and a volume spike to 2,075,140 shares. No new earnings release was posted. The move reflects short-term momentum and trader interest in small-cap healthcare listings.

What is Meyka AI’s forecast for 1ST.AX stock?

Meyka AI's forecast model projects a one-year price of A$0.00718 versus the current A$0.011, implying an expected decline of about 34.75%. Forecasts are model-based projections and not guarantees.

What are realistic price targets for 1ST.AX stock?

Scenario targets: base A$0.015, optimistic A$0.020, and downside A$0.004. Targets reflect thin liquidity, negative EPS, and marketplace growth potential. Adjust targets if company news or funding changes.

Should I trade 1ST.AX stock after the pre-market surge?

Treat 1ST.AX as high volatility. Use small position sizes, limit orders and tight stops. The stock has negative earnings and thin float, increasing risk for rapid reversals.

AU Stocks

1ST.AX up 22% pre-market on ASX: top gainer watch at A$0.011

ByDanny Kontos February 19, 2026

1ST.AX stock jumped 22.22% in pre-market trading on 19 Feb 2026, moving to A$0.011 on the ASX. Volume surged to 2,075,140 shares, three times the daily average. The move makes 1st Group Limited (1ST.AX) one of today’s top gainers in the Healthcare sector in Australia. We examine the drivers, the financial snapshot, and what our models forecast for near-term price action.